ADIPOQ and depressive symptom measurement: These results seem inconsistent and paradoxical but probably arise from individual research limitations, including heterogeneity, sample size, and potential publication bias, BMI, depression severity, and heterogeneity of depressive disorders, and differences in assay types for adiponectin and leptin [23–25, 45].